Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis.

Touma Z, Gladman DD, Urowitz MB, Beyene J, Uleryk EM, Shah PS.

J Rheumatol. 2011 Jan;38(1):69-78. doi: 10.3899/jrheum.100130. Epub 2010 Oct 15. Review.

PMID:
20952473
2.

Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.

Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.

Nephrol Dial Transplant. 2007 Jul;22(7):1933-42. Epub 2007 Apr 3. Review.

PMID:
17405792
3.

Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.

Kamanamool N, McEvoy M, Attia J, Ingsathit A, Ngamjanyaporn P, Thakkinstian A.

Medicine (Baltimore). 2010 Jul;89(4):227-35. doi: 10.1097/MD.0b013e3181e93d00. Review.

4.

Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.

Lee YH, Woo JH, Choi SJ, Ji JD, Song GG.

Lupus. 2010 May;19(6):703-10. doi: 10.1177/0961203309357763. Epub 2010 Jan 11. Review.

PMID:
20064907
5.

Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.

Liu LL, Jiang Y, Wang LN, Yao L, Li ZL.

Drugs. 2012 Jul 30;72(11):1521-33. doi: 10.2165/11635030-000000000-00000. Review.

PMID:
22818016
6.

Treatment for lupus nephritis.

Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF, Webster AC.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002922. doi: 10.1002/14651858.CD002922.pub3. Review.

PMID:
23235592
7.

Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis.

Tian SY, Feldman BM, Beyene J, Brown PE, Uleryk EM, Silverman ED.

J Rheumatol. 2015 Aug;42(8):1392-400. doi: 10.3899/jrheum.141650. Epub 2015 Jun 15. Review.

PMID:
26077406
8.

Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.

Tian SY, Feldman BM, Beyene J, Brown PE, Uleryk EM, Silverman ED.

J Rheumatol. 2014 Oct;41(10):1998-2007. doi: 10.3899/jrheum.140050. Epub 2014 Sep 15. Review.

PMID:
25225281
9.

Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.

Feng L, Deng J, Huo DM, Wu QY, Liao YH.

Nephrology (Carlton). 2013 Feb;18(2):104-10. doi: 10.1111/nep.12006. Review.

PMID:
23113811
10.

What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?

Jones RB, Walsh M, Smith KG.

Curr Opin Rheumatol. 2009 May;21(3):256-61. Review.

PMID:
19399995
12.

Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis.

Singh JA, Hossain A, Kotb A, Oliveira A, Mudano AS, Grossman J, Winthrop K, Wells GA.

J Rheumatol. 2016 Oct;43(10):1801-1815. Epub 2016 Sep 1. Review.

13.

Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?

Rovin BH, Parikh SV, Hebert LA, Chan TM, Mok CC, Ginzler EM, Hooi LS, Brunetta P, Maciuca R, Solomons N.

Clin J Am Soc Nephrol. 2013 Jan;8(1):147-53. doi: 10.2215/CJN.03290412. Epub 2012 Aug 9. Review.

14.

Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.

Walsh M, James M, Jayne D, Tonelli M, Manns BJ, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2007 Sep;2(5):968-75. Epub 2007 Aug 8. Review.

15.

Can mycophenolate mofetil substitute cyclophosphamide treatment of pediatric lupus nephritis?

Paredes A.

Pediatr Nephrol. 2007 Aug;22(8):1077-82. Epub 2007 Mar 17. Review.

PMID:
17370094
16.

The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.

Zhang X, Ji L, Yang L, Tang X, Qin W.

Int Urol Nephrol. 2016 May;48(5):731-43. doi: 10.1007/s11255-015-1201-z. Epub 2016 Jan 19. Review.

PMID:
26781720
17.

Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?

Hogan J, Schwenk MH, Radhakrishnan J.

Kidney Int. 2012 Dec;82(12):1256-60. doi: 10.1038/ki.2012.203. Epub 2012 May 30. Review.

18.

Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis.

Singh JA, Hossain A, Kotb A, Wells GA.

Syst Rev. 2016 Sep 13;5(1):155. doi: 10.1186/s13643-016-0328-z. Review.

19.

Mycophenolate mofetil in lupus nephritis.

Ginzler EM, Aranow C.

Lupus. 2005;14(1):59-64. Review.

PMID:
15732290
20.

Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.

Singh JA, Hossain A, Kotb A, Wells G.

BMC Med. 2016 Sep 13;14(1):137. doi: 10.1186/s12916-016-0673-8. Review.

Supplemental Content

Support Center